Pablo Pfister
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pablo Pfister has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Arnaud Scherberich
Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Basel, 4031 Basel, Switzerland
2 shared publications - Adrien Moya
Department of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland
1 shared publication - Alexandre Kaempfen
Department of Plastic Reconstructive Aesthetic and Hand Surgery University Hospital Basel Basel Switzerland
1 shared publication - Ana Pérez Dominguez
Center for Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, Plattenstrasse 11, 8032 Zurich, Switzerland
1 shared publication - Andrés García-García
Department of Biomedicine University of Basel University Hospital of Basel Basel Switzerland
1 shared publication - Chafik Ghayor
Center of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zurich, 8032 Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (14) , e04880
Start, Stop, Rewind, Repeat—Cyclic Exposure of Adipose Stromal Cells‐derived Cartilage Organoids to Chondrogenic and Proliferative Cues to Achieve Scaled‐up and Customizable Bone Formation by Endochondral Ossification
Developmental tissue engineering (TE) strategies recapitulating endochondral ossification (ECO)—the major ossification pathway in bone development and repair– are a promising avenue for the treatment of critical size and congenital bone defects. In this work, we develop a customizable approach using adipose stromal cells (ASC)‐derived cartilage organoids as building blocks to generate clinically relevant grafts. Our hypothesis is that progenitor cells rather than mature chondrocytes would enable robust cartilage organoids fusion allowing graft tunability and scaling up. Using a cyclic approach alternating chondrogenic and proliferative cues we produce cartilage organoids surrounded by stromal chondrogenic progenitors. When re‐exposed to chondrogenic medium, this perichondrial layer forms new cartilage tissue and acts as a biological cement in between cartilage organoids. A key feature of our approach is the iterative aspect of the protocol, where scaled up cartilage tissues obtained can themselves be used as building blocks to create larger tissue. Finally, in vivo, these grafts remodel efficiently into functional and mechanically apt bone organs mirroring ECO during skeletal development over the course of 24 weeks. Collectively, our findings provide a strong proof of concept of the envisioned TE strategy paving the way for a clinical application in the near future.
- 9 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (14) , e04880
Open AccessStart, Stop, Rewind, Repeat—Cyclic Exposure of Adipose Stromal Cells‐derived Cartilage Organoids to Chondrogenic and Proliferative Cues to Achieve Scaled‐up and Customizable Bone Formation by Endochondral Ossification
Developmental tissue engineering (TE) strategies recapitulating endochondral ossification (ECO)—the major ossification pathway in bone development and repair– are a promising avenue for the treatment of critical size and congenital bone defects. In this work, we develop a customizable approach using adipose stromal cells (ASC)‐derived cartilage organoids as building blocks to generate clinically relevant grafts. Our hypothesis is that progenitor cells rather than mature chondrocytes would enable robust cartilage organoids fusion allowing graft tunability and scaling up. Using a cyclic approach alternating chondrogenic and proliferative cues we produce cartilage organoids surrounded by stromal chondrogenic progenitors. When re‐exposed to chondrogenic medium, this perichondrial layer forms new cartilage tissue and acts as a biological cement in between cartilage organoids. A key feature of our approach is the iterative aspect of the protocol, where scaled up cartilage tissues obtained can themselves be used as building blocks to create larger tissue. Finally, in vivo, these grafts remodel efficiently into functional and mechanically apt bone organs mirroring ECO during skeletal development over the course of 24 weeks. Collectively, our findings provide a strong proof of concept of the envisioned TE strategy paving the way for a clinical application in the near future.
- Open Access
- 21 May 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 200, 686-702
Mineralized osteoblast-derived exosomes and 3D-printed ceramic-based scaffolds for enhanced bone healing: A preclinical exploration
- 21 May 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 200, 686-702
Open AccessMineralized osteoblast-derived exosomes and 3D-printed ceramic-based scaffolds for enhanced bone healing: A preclinical exploration